ch.correia
TL2 Moderator · Turku
Contributes reviews on supplier material. Based in Turku.
Joined 14 July 2025 · last posted 3d
80 posts, newest first. Showing up to 150.
-
How shortages have affected compounding permissions Replied, post #67 · Access › Shortages · 25 Jul 2026 · 2 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #91 · Access › Insurance & coverage · 23 Jul 2026 · 3 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
NHS criteria and how they are applied in practice Replied, post #27 · Regional › UK & Ireland · 12 Jul 2026 · 11 likes Worth separating two things that post #23 runs together. Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent…
-
What is genuinely unknown about long-term amylin agonism Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2026 · 10 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
Micro-titration: a disputed topic, argued properly Replied, post #94 · Practice › Dosing & titration · 24 Jun 2026 · 25 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Micronutrient adequacy at low total intake Replied, post #21 · Nutrition & Training › Protein & intake · 7 Jun 2026 · 0 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #64 · Devices › Syringes & needles · 6 Jun 2026 · 32 likes post #63 is right about the mechanism and I think understates the practical bit. Aspirating before injection: for subcutaneous injection, aspirating (pulling back on…
-
How to disagree with an answer you were given, well Replied, post #6 · Start Here › How to Ask · 5 Jun 2026 · 14 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Injecting into an area that has become firm: why not to Replied, post #12 · Practice › Administration · 4 Jun 2026 · 1 like On post #8 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #37 · Practice › Storage & stability · 4 Jun 2026 · 1 like Coming back to post #35, because the follow-up matters more than the original answer. Container choice matters: the material of the vial, the rubber closure, the fill…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #51 · Evidence › Journal club · 30 May 2026 · 3 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Micro-titration: a disputed topic, argued properly Replied, post #75 · Practice › Dosing & titration · 16 May 2026 · 20 likes This follows post #72 rather than contradicting it. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure,…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #18 · Evidence › Trials · 10 May 2026 · 3 likes post #17 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Follow-up: How to disagree with an answer you were given, well Replied, post #2 · Start Here › How to Ask · 4 May 2026 · 0 likes the opening post answers the question as asked. The question underneath it is different. Asking a follow-up: new topic or reply in the old one? If the answer depends on…
-
A parcel stationary at a customs facility for nine days Replied, post #55 · Sourcing › Logistics · 3 May 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #65 · Evidence › Trials · 29 Apr 2026 · 6 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #29 · Clinical › Bloodwork · 2 Apr 2026 · 0 likes Worth separating two things that post #25 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Journal club: is percentage weight change the right endpoint? Replied, post #14 · Evidence › Journal club · 25 Mar 2026 · 0 likes I read post #12 twice before replying, because I had assumed the opposite. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #62 · Practice › Storage & stability · 12 Mar 2026 · 17 likes Worth separating two things that post #58 runs together. I want to gently push back on the reply above about storage extrapolation. The advice is sound and the…
-
Second pass at: Identical chromatograms across two different lots Replied, post #54 · Sourcing › Red flags · 9 Mar 2026 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #10 · Analytics › HPLC & UHPLC · 19 Feb 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Designing a personal experiment that could change your mind — one year on Replied, post #9 · Research Methods › N-of-1 designs · 8 Feb 2026 · 0 likes I read post #7 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #119 · Analytics › COA interpretation · 27 Jan 2026 · 25 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
The headache that turns out to be dehydration Replied, post #124 · Nutrition & Training › Hydration & electrolytes · 4 Jan 2026 · 25 likes On post #120 — agreed on the reasoning, with one qualification. Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #34 · Outcomes › Body composition · 1 Jan 2026 · 30 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #30 · Clinical › Bloodwork · 1 Jan 2026 · 9 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Citation sweep results: how many references did not say what was claimed Replied, post #24 · Meta › Wiki maintenance · 30 Dec 2025 · 17 likes Coming back to post #22, because the follow-up matters more than the original answer. Maintainer handovers: if a page's maintainer is inactive and needs a new one,…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #30 · Practice › Side effects · 27 Dec 2025 · 0 likes I read post #28 twice before replying, because I had assumed the opposite. Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training…
-
Dead volume across syringe and needle combinations Replied, post #43 · Devices › Syringes & needles · 24 Dec 2025 · 6 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
DXA precision and the least significant change for lean mass Replied, post #83 · Outcomes › Body composition · 19 Dec 2025 · 0 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
-
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Replied, post #9 · Compounds › Tirzepatide · 18 Dec 2025 · 32 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #68 · Clinical › Special populations · 16 Dec 2025 · 2 likes post #67 is right about the mechanism and I think understates the practical bit. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating…
-
Adolescents: a distinct evidence base — one year on Replied, post #43 · Clinical › Special populations · 13 Dec 2025 · 28 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #8 · Access › International · 11 Dec 2025 · 12 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Second pass at: Programming during a large energy deficit Replied, post #46 · Nutrition & Training › Resistance training · 19 Oct 2025 · 0 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
A comparison of home results against a laboratory result on the same vial Replied, post #51 · Analytics › Home & field testing · 19 Oct 2025 · 27 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A 40-week log with the measurement method stated Replied, post #33 · Outcomes › Progress reports · 19 Oct 2025 · 2 likes On post #29 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #71 · Sourcing › Vendor reports · 11 Oct 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #67 · Start Here › How to Ask · 10 Oct 2025 · 1 like Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #42 · Evidence › Preprints · 29 Sep 2025 · 0 likes post #41 is right about the mechanism and I think understates the practical bit. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
-
Titles that describe the question, not the situation Replied, post #95 · Start Here › How to Ask · 13 Sep 2025 · 6 likes Picking up post #92: that is the part I would want checked first. Lab result questions: state the result, the reference interval, and what else is on the same panel. A…
-
Comparing my trajectory with the trial curves, carefully Replied, post #45 · Outcomes › Progress reports · 6 Sep 2025 · 0 likes post #44 is right about the mechanism and I think understates the practical bit. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is…
-
A preprint whose numbers changed substantially at publication Replied, post #37 · Evidence › Preprints · 1 Sep 2025 · 6 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #70 · Data & Tools › Calculators · 2 Aug 2025 · 14 likes Picking up post #67: that is the part I would want checked first. Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #14 · Practice › Side effects · 2 Aug 2025 · 17 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #95 · Compounds › Tirzepatide · 27 Jul 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #12 · Practice › Storage & stability · 23 Jul 2025 · 0 likes Coming back to post #10, because the follow-up matters more than the original answer. Beyond-use dating: the date after which a prepared solution should not be used. It…
-
A field-by-field walk through a certificate of analysis Replied, post #94 · Analytics › COA interpretation · 17 Jul 2025 · 0 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
A supplier that answers analytical questions with restated claims Replied, post #118 · Sourcing › Red flags · 14 Jul 2025 · 5 likes I read post #116 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is…
-
Sequence verification for an obscure compound: how it is done Replied, post #85 · Compounds › Other compounds · 7 Jul 2025 · 1 like Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Revisiting: Food effects on oral incretin absorption: what is documented Started this topic · Compounds › Oral incretins · 28 Jun 2025 · 55 likes Revisiting: Food effects on oral incretin absorption: what is documented — setting out what I have, and where I think it stops being reliable. Session topic: SURMOUNT-2…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #74 · Compounds › Tirzepatide · 20 Jun 2025 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Titrating on tolerability rather than on the calendar Replied, post #2 · Practice › Dosing & titration · 19 Jun 2025 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #111 · Compounds › Cagrilintide & amylin analogues · 16 Jun 2025 · 7 likes I read post #109 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #95 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 0 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #50 · Devices › Pens & autoinjectors · 27 May 2025 · 1 like Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #18 · Analytics › Home & field testing · 22 May 2025 · 1 like post #17 is right about the mechanism and I think understates the practical bit. Why third-party testing is stronger: a home test run by the person who made the…
-
Dizziness on standing: the ordinary explanation first Replied, post #26 · Nutrition & Training › Hydration & electrolytes · 29 Apr 2025 · 19 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #65 · Practice › Interactions · 29 Apr 2025 · 22 likes post #64 answers the question as asked. The question underneath it is different. Thyroid medications: semaglutide is associated with a slowing of gastric emptying,…
-
Asking about a compound your prescriber has not heard of Replied, post #24 · Clinical › Prescriber conversations · 25 Apr 2025 · 2 likes This follows post #21 rather than contradicting it. Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A…
-
Reading a trial's population section before its results — does this still hold? Replied, post #12 · Evidence › Trials · 15 Apr 2025 · 23 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #28 · Regional › UK & Ireland · 7 Apr 2025 · 13 likes Picking up post #25: that is the part I would want checked first. Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only.…
-
Patterns that reliably precede a problem, documented Replied, post #8 · Sourcing › Red flags · 31 Mar 2025 · 14 likes post #7 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #16 · Evidence › Trials · 22 Mar 2025 · 0 likes Coming back to post #14, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #22 · Clinical › Bloodwork · 17 Jan 2025 · 27 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #10 · Compounds › Oral incretins · 25 Dec 2024 · 23 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Building a sensible monitoring schedule with your prescriber Replied, post #67 · Clinical › Bloodwork · 21 Dec 2024 · 1 like Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Gallbladder disease risk with rapid weight loss Replied, post #42 · Clinical › Comorbidities · 11 Dec 2024 · 2 likes On post #38 — agreed on the reasoning, with one qualification. Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #28 · Practice › Interactions · 1 Dec 2024 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #28 · Compounds › Other compounds · 27 Nov 2024 · 0 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #45 · Compounds › Repair & healing peptides · 13 Nov 2024 · 17 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #101 · Practice › Dosing & titration · 10 Nov 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Signs of dehydration worth acting on Replied, post #35 · Safety › Adverse events · 26 Oct 2024 · 24 likes post #34 is right about the mechanism and I think understates the practical bit. Reporting to regulatory agencies: if you have had a serious event, reporting it to the…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #71 · Clinical › Comorbidities · 21 Oct 2024 · 20 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reading a supplementary appendix and finding the interesting part Replied, post #8 · Evidence › Trials · 18 Oct 2024 · 0 likes post #7 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Requesting a page: what makes a good request — what changed since Replied, post #18 · Documentation › Wiki requests · 9 Oct 2024 · 9 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Progressive overload when the scale is falling — one year on Replied, post #55 · Nutrition & Training › Resistance training · 14 Sep 2024 · 2 likes post #54 is right about the mechanism and I think understates the practical bit. Post-weight-loss training: once weight loss is complete and energy deficit ends,…
-
Reporting a discrepancy without making an allegation Replied, post #57 · Sourcing › Vendor reports · 4 Sep 2024 · 9 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Pen wastage and its effect on real cost Replied, post #16 · Access › Pricing · 16 Aug 2024 · 5 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
-
Blind submission and why it changes minds Replied, post #20 · Sourcing › Independent verification · 22 Jul 2024 · 0 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…